Login
$CPHI
$0.62 -$0.01 (1.59%) Close

Insider Transactions

What China Pharma Holdings Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Li Zhilin CEO & Interim CFO Sep 29 Grant / award · A +13,757,063 $0.14 +$1.93M 15,138,063
Li Zhilin CEO & Interim CFO Sep 09 Grant / award · A +1,760,000 $0.67 +$1.18M 13,810,000
Li Zhilin CEO and interim CFO Dec 23 Grant / award · A +2,000,000 — — 12,050,000
Waung Frank Chief Financial Officer Apr 28 Grant / award · A +100,000 — — 138,415
Waung Frank Chief Financial Officer May 25 Grant / award · A +25,000 — — 38,415
Li Zhilin President and CEO May 25 Grant / award · A +50,000 — — 10,050,000
Waung Frank Chief Financial Officer Dec 13 Grant / award · A +6,863 — — 13,415
Waung Frank Chief Financial Officer Nov 15 Exercise / conversion · M +4,052 — — 6,552
Tsui Heung Mei Director Feb 09 Grant / award · A −1,500,000 $3.00 −$4.5M 9,312,651
Li Zhilin President and CEO Sep 13 Grant / award · A +10,000,000 — — 10,000,000
Tsui Heung Mei Director Sep 13 Grant / award · A −10,000,000 — — 15,278,385
Tsui Heung Mei Director May 16 Grant / award · A +4,723,056 $0.00 +$4.72K 25,278,385
Halter Timothy P CEO, Pres, CFO, Chairman & Sec Oct 04 Other Transaction · J −46,875 — — 0
Halter Timothy P CEO, Pres, CFO, Chairman & Sec Oct 04 Open-market sale · S −1,828,170 $0.10 −$183K 0

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support